Gallbladder Cancer Incidence and Mortality, United States 1999–2011

Henley, S. Jane; Weir, Hannah K.; Jim, Melissa A.; Watson, Meg; Richardson, Lisa C.

doi:10.1158/1055-9965.epi-15-0199

Cited by 120 publications

(89 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In agreement with prior studies, we found that GBC incidence rates were highest among women, Hispanics, and older age groups . These differences between demographic groups in GBC incidence rates may be explained by variations in risk factor prevalence by sex and race/ethnicity.…”

Section: Discussionsupporting

confidence: 92%

See 1 more Smart Citation

Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013

Dyke

Shiels

Jones

et al. 2019

Cancer

130

110

View full text Add to dashboard Cite

Background Biliary tract cancers (BTCs) are rare but deadly cancers (gallbladder cancer [GBC], intrahepatic cholangiocarcinoma [ICC], extrahepatic cholangiocarcinoma [ECC], and ampulla of Vater cancer [AVC]). A recent US study reported increasing GBC incidence among people younger than 45 years and blacks; however, it did not examine trends for other biliary tract sites. Methods This study characterized demographic differences in BTC incidence rates and time trends by anatomic site. Population‐based North American Association of Central Cancer Registries data were used to calculate age‐adjusted incidence rates, incidence rate ratios (IRRs), and estimated annual percent changes (eAPCs) for 1999‐2013 by site and demographic group. For sites with significant differences in eAPC by age group, IRRs were compared by age group. Results GBC incidence rates declined among women (eAPC, –0.5%/y; P = .01) and all racial/ethnic groups except for non‐Hispanic blacks, among whom rates increased (1.8%/y; P < .0001). Although GBC rates increased among 18‐ to 44‐year‐olds (eAPC, 1.8%/y; P = .01), they decreased among people 45 years old or older (–0.4%/y; P = .009). Sex (P < .0001) and racial/ethnic differences (P = .003 to .02) in GBC incidence were larger for younger people than older people. During this period, ICC (eAPC, 3.2%/y; P < .0001) and ECC rates (1.8%/y; P = .001) steadily increased across sex and racial/ethnic groups. Although AVC incidence rates increased among younger adults (eAPC, 1.8%/y; P = .03) but not older adults (–0.20%/y; P = .30), sex and racial/ethnic IRRs did not differ by age. Conclusions Differential patterns of BTC rates and temporal trends have been identified by anatomic site and demographic groups. These findings highlight the need for large pooling projects to evaluate BTC risk factors by anatomic site.

show abstract

Section: Discussionsupporting

confidence: 92%

“…Overall, GBC incidence rates declined, but trends differed by demographics. Although the incidence declined among females, rates remained stable among males .…”

Section: Discussionmentioning

confidence: 95%

Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013

Dyke

Shiels

Jones

et al. 2019

Cancer

130

110

View full text Add to dashboard Cite

show abstract

“…In 2018, an estimated 1000 Hispanic women will be diagnosed with gallbladder cancer. Hispanic women in the United States have the second highest incidence and mortality rates after American Indian/Alaska Native women . The incidence rate in Hispanic women (2.5 per 100,000) is double that of Hispanic men (1.2 per 100,000) and NHW women (1.1 per 100,000) and triple that of NHW men (0.7 per 100,000) (Table ).…”

Section: Selected Findingsmentioning

confidence: 99%

Cancer Statistics for Hispanics/Latinos, 2018

Miller

Sauer

Ortiz³

et al. 2018

CA A Cancer J Clinicians

385

296

View full text Add to dashboard Cite

Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.8% (57.5 million) of the total population in the continental United States and Hawaii in 2016. In addition, more than 3 million Hispanic Americans live in the US territory of Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanics in the United States based on data from the National Cancer Institute, the North American Association of Central Cancer Registries, and the Centers for Disease Control and Prevention. For the first time, contemporary incidence and mortality rates for Puerto Rico, which has a 99% Hispanic population, are also presented. An estimated 149,100 new cancer cases and 42,700 cancer deaths will occur among Hispanics in the continental United States and Hawaii in 2018. For all cancers combined, Hispanics have 25% lower incidence and 30% lower mortality compared with non‐Hispanic whites, although rates of infection‐related cancers, such as liver, are up to twice as high in Hispanics. However, these aggregated data mask substantial heterogeneity within the Hispanic population because of variable cancer risk, as exemplified by the substantial differences in the cancer burden between island Puerto Ricans and other US Hispanics. For example, during 2011 to 2015, prostate cancer incidence rates in Puerto Rico (146.6 per 100,000) were 60% higher than those in other US Hispanics combined (91.6 per 100,000) and 44% higher than those in non‐Hispanic whites (101.7 per 100,000). Prostate cancer is also the leading cause of cancer death among men in Puerto Rico, accounting for nearly 1 in 6 cancer deaths during 2011‐2015, whereas lung cancer is the leading cause of cancer death among other US Hispanic men combined. Variations in cancer risk are driven by differences in exposure to cancer‐causing infectious agents and behavioral risk factors as well as the prevalence of screening. Strategies for reducing cancer risk in Hispanic populations include targeted, culturally appropriate interventions for increasing the uptake of preventive services and reducing cancer risk factor prevalence, as well as additional funding for Puerto Rico‐specific and subgroup‐specific cancer research and surveillance.

show abstract

“…Information regarding gallbladder cancer in the scientific literature is scant due to its rarity, particularly in economically developed countries. In the United States, Hispanic women have the second highest incidence and mortality rates after American Indian/Alaska Native women . The incidence rate in Hispanic women (2.6 per 100,000 population) is double that of Hispanic men (1.2) and NHW women (1.1) and triple that of NHW men (0.7) (Table ).…”

Section: Selected Findingsmentioning

confidence: 99%

Cancer statistics for Hispanics/Latinos, 2015

Siegel

Fedewa

Miller

et al. 2015

CA A Cancer J Clinicians

424

398

View full text Add to dashboard Cite

Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethnic minority group in the United States, accounting for 17.4% (55.4 million/318 million) of the total US population in 2014. Every 3 years, the American Cancer Society reports on cancer statistics for Hispanics based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Among Hispanics in 2015, there will be an estimated 125,900 new cancer cases diagnosed and 37,800 cancer deaths. For all cancers combined, Hispanics have 20% lower incidence rates and 30% lower death rates compared with non‐Hispanic whites (NHWs); however, death rates are slightly higher among Hispanics during adolescence (aged 15‐19 years). Hispanic cancer rates vary by country of origin and are generally lowest in Mexicans, with the exception of infection‐associated cancers. Liver cancer incidence rates in Hispanic men, which are twice those in NHW men, doubled from 1992 to 2012; however, rates in men aged younger than 50 years declined by 43% since 2003, perhaps a bellwether of future trends for this highly fatal cancer. Variations in cancer risk between Hispanics and NHWs, as well as between subpopulations, are driven by differences in exposure to cancer‐causing infectious agents, rates of screening, and lifestyle patterns. Strategies for reducing cancer risk in Hispanic populations include increasing the uptake of preventive services (eg, screening and vaccination) and targeted interventions to reduce obesity, tobacco use, and alcohol consumption. CA Cancer J Clin 2015;65:457–480. © 2015 American Cancer Society.

show abstract

Gallbladder Cancer Incidence and Mortality, United States 1999–2011

Cited by 120 publications

References 21 publications

Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013

Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013

Cancer Statistics for Hispanics/Latinos, 2018

Cancer statistics for Hispanics/Latinos, 2015

Contact Info

Product

Resources

About